LandBridge Co. LLC(LB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LB LandBridge Co. LLC

Market Closed 02-20 16:00:00 EST

68.52

+1.62

+2.42%

盘后70.00

+1.48+2.16%

18:31 EST

High68.89	Low65.25	Vol538.32K
Open66.70	D1 Closing66.90	Amplitude5.44%
Mkt Cap5.24B	Tradable Cap3.73B	Total Shares76.43M
T/O36.53M	T/O Rate0.99%	Tradable Shares54.50M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LB","market":"US","secType":"STK","nameCN":"LandBridge Co. LLC","latestPrice":68.52,"timestamp":1771621200000,"preClose":66.9,"halted":0,"volume":538320,"hourTrading":{"tag":"盘后","latestPrice":69.9999,"preClose":68.52,"latestTime":"18:31 EST","volume":1041,"amount":71944.8,"timestamp":1771630280937,"change":1.4799,"changeRate":0.021598,"amplitude":0.021598},"delay":0,"changeRate":0.024215246636771152,"floatShares":54504591,"shares":76431700,"eps":0.741561,"marketStatus":"Market Closed","change":1.62,"latestTime":"02-20 16:00:00 EST","open":66.7,"high":68.89,"low":65.2501,"amount":36526559.67,"amplitude":0.054408,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.741561,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1719547200000,"exchange":"NYSE","adjPreClose":66.9,"dividendRate":0.005844,"preHourTrading":{"tag":"盘前","latestPrice":66.02,"preClose":66.9,"latestTime":"09:10 EST","volume":396,"amount":26623.97496,"timestamp":1771596640207,"change":-0.88,"changeRate":-0.013154,"amplitude":0.028999},"postHourTrading":{"tag":"盘后","latestPrice":69.9999,"preClose":68.52,"latestTime":"18:31 EST","volume":1041,"amount":71944.8,"timestamp":1771630280937,"change":1.4799,"changeRate":0.021598,"amplitude":0.021598},"volumeRatio":0.9658847051970098,"impliedVol":0.6579,"impliedVolPercentile":0.7729},"requestUrl":"/m/hq/s/LB/wiki","defaultTab":"wiki","newsList":[{"id":"1138006452","title":"Earning Preview: LandBridge Co. LLC Q4 revenue is expected to increase by N/A, and institutional views are mostly bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1138006452","media":"Earnings Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1138006452?lang=en_us&edition=fundamental","pubTime":"2026-02-18 16:05","pubTimestamp":1771401945,"startTime":"0","endTime":"0","summary":"Abstract LandBridge Co. LLC will release its quarterly results on February 25, 2026 Post Market; this preview compiles the latest forecasts, key segment dynamics, and institutional expectations for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: LandBridge Co. LLC Q4 revenue is expected to increase by N/A, and institutional views are mostly bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LB"],"gpt_icon":0},{"id":"2612289553","title":"LB Pharmaceuticals management to meet with Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2612289553","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612289553?lang=en_us&edition=fundamental","pubTime":"2026-02-19 23:46","pubTimestamp":1771515994,"startTime":"0","endTime":"0","summary":"Meeting to be held in Boston on February 23 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving b...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-management-to-meet-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-management-to-meet-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4233","LBRX","BK4007","BK4213","LB"],"gpt_icon":0},{"id":"2610997383","title":"LB Group Plans Plans Up to 2-Billion-Yuan Short-Term Bond Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2610997383","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610997383?lang=en_us&edition=fundamental","pubTime":"2026-02-12 12:15","pubTimestamp":1770869732,"startTime":"0","endTime":"0","summary":"LB Group  plans to issue up to 2 billion yuan in short-term commercial papers, with terms of up to one year.Proceeds will be used for working capital and loan repayment pending shareholder and regulatory approval, according to a Thursday filing with the Shenzhen bourse.Shares of the titanium dioxide pigment producer rose 1% in recent trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0193","BK4213","US7Y.BOND","BK0187","BK0131","BK0196","TMF","TLTW","US2Y.BOND","LB","BK0028","BK0229","US5Y.BOND","US6M.BOND","TLT","US3Y.BOND","US30Y.BOND","002601","BK0197","BK4233","US10Y.BOND","US12M.BOND"],"gpt_icon":0},{"id":"2610671903","title":"LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2610671903","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610671903?lang=en_us&edition=fundamental","pubTime":"2026-02-11 05:41","pubTimestamp":1770759660,"startTime":"0","endTime":"0","summary":"NEW YORK, Feb.  10, 2026  (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced that it has granted to Dr. Minako Pazdera, the new General C","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/10/3235822/0/en/LB-Pharmaceuticals-Reports-Inducement-Grant-to-New-Employee-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LB","BK4233","LBRX","BK4213","BK4007"],"gpt_icon":0},{"id":"2610668583","title":"LIXTE Biotechnology (NASDAQ: LIXT) Positions LB-100 to Expand Effectiveness of Standard Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2610668583","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610668583?lang=en_us&edition=fundamental","pubTime":"2026-02-10 02:30","pubTimestamp":1770661807,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, February 9th, 2026, FinanceWire LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/lixte-biotechnology-nasdaq-lixt-positions-lb-100-to-expand-effectiveness-of-standard-cancer-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/lixte-biotechnology-nasdaq-lixt-positions-lb-100-to-expand-effectiveness-of-standard-cancer-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SMP","JEPQ","BK4233","QYLD","QQQM","USJW.SI","PSQ","BK4139","GPIQ","QYLG","BK4124","QQQ","QLD",".IXIC","NDX","NQmain","BK4213","QQQJ","QQQE","QQQY","SQQQ","USAW.SI","LIXT","MNQmain","QID","TSYW.SI","LB","TQQQ","NVIW.SI"],"gpt_icon":0},{"id":"2609517308","title":"Press Release: LB Pharmaceuticals Announces $100.0 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2609517308","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609517308?lang=en_us&edition=fundamental","pubTime":"2026-02-05 21:00","pubTimestamp":1770296400,"startTime":"0","endTime":"0","summary":"NEW YORK, Feb. 05, 2026  -- LB Pharmaceuticals Inc  , a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, and other neuropsychiatric diseases, today announced that it has entered into a securities purchase agreement to sell 3,306,571 shares of its common stock and pre-funded warrants to purchase up to 1,417,107 shares of its common stock to a select group of institutional investors in a private placement. The purchase price of each share of common stock is $21.17. The purchase price of each pre-funded warrant is $21.1699, which represents the per share purchase price for the common stock less the $0.0001 per share exercise price for such pre-funded warrant. LB Pharmaceuticals anticipates the gross proceeds from the private placement to be approximately $100.0 million, before deducting any transaction-related expenses. The private placement is expected to close on or about February 6, 2026, subject to the satisfaction of customary clo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4233","BK4213","LBRX","LB","BK4007"],"gpt_icon":0},{"id":"2606736790","title":"LB Pharmaceuticals Advances LB-102 Into Long-Term Phase 3 Safety Study for Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2606736790","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606736790?lang=en_us&edition=fundamental","pubTime":"2026-01-28 00:31","pubTimestamp":1769531479,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals, Inc. ($LBRX) announced an update on their ongoing clinical study. Study Overview LB Pharmaceuticals, Inc. (LBRX) has launched a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lb-pharmaceuticals-advances-lb-102-into-long-term-phase-3-safety-study-for-schizophrenia?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lb-pharmaceuticals-advances-lb-102-into-long-term-phase-3-safety-study-for-schizophrenia?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4213","LBRX","BK4233","LB"],"gpt_icon":0},{"id":"2606173393","title":"Roth MKM Keeps Their Buy Rating on LB Pharmaceuticals, Inc. (LBRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2606173393","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606173393?lang=en_us&edition=fundamental","pubTime":"2026-01-27 22:55","pubTimestamp":1769525759,"startTime":"0","endTime":"0","summary":"Roth MKM analyst Boobalan Pachaiyappan maintained a Buy rating on LB Pharmaceuticals, Inc. today and set a price target of $31.00. Pachaiyappan cov...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-keeps-their-buy-rating-on-lb-pharmaceuticals-inc-lbrx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-keeps-their-buy-rating-on-lb-pharmaceuticals-inc-lbrx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LB","LBRX"],"gpt_icon":0},{"id":"2605840414","title":"LB Pharmaceuticals Advances LB-102 Into Phase 3, Setting Up a Key Schizophrenia Catalyst for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2605840414","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605840414?lang=en_us&edition=fundamental","pubTime":"2026-01-24 00:33","pubTimestamp":1769185981,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals, Inc. ($LBRX) announced an update on their ongoing clinical study. Study Overview LB Pharmaceuticals, Inc. is launching a late-s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lb-pharmaceuticals-advances-lb-102-into-phase-3-setting-up-a-key-schizophrenia-catalyst-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lb-pharmaceuticals-advances-lb-102-into-phase-3-setting-up-a-key-schizophrenia-catalyst-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISBC","LB","LBRX","BK4233","BK4211","BK4213","BK4007"],"gpt_icon":0},{"id":"2605491229","title":"Press Release: LandBridge Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2605491229","media":"Dow Jones","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605491229?lang=en_us&edition=fundamental","pubTime":"2026-01-22 21:31","pubTimestamp":1769088660,"startTime":"0","endTime":"0","summary":"LandBridge Company LLC   today announced that it will release its financial results for the fourth quarter and the fiscal year ended December 31, 2025 after market close on Wednesday, February 25, 2026.LandBridge will host a webcast and conference call to discuss its results on Thursday, February 26, 2026, at 10 a.m. Central Time / 11:00 a.m. Eastern Time.To listen to the live webcast, please visit the Events and Presentations section of the LandBridge Investor Relations website. Please visit the site at least 10-15 minutes prior to the scheduled start time to register and install any necessary audio software. The webcast will be archived on the site for those unable to listen in real-time.pwd=zz0XWN to receive unique dial-in information. Pre-registration may be completed at any time up to the call start time.LandBridge owns more than 300,000 surface acres across Texas and New Mexico, located primarily in the heart of the Delaware sub-region in the Permian Basin, the most active region","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4233","LB","BK4213"],"gpt_icon":0},{"id":"2605107699","title":"LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General Counsel","url":"https://stock-news.laohu8.com/highlight/detail?id=2605107699","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605107699?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:00","pubTimestamp":1769000400,"startTime":"0","endTime":"0","summary":"NEW YORK, Jan.  21, 2026  (GLOBE NEWSWIRE) -- LB Pharmaceuticals, Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a clinical-stage biopharmaceutical company developing novel therapies for ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/21/3222743/0/en/LB-Pharmaceuticals-Appoints-Minako-Pazdera-J-D-Ph-D-as-General-Counsel.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","LB","BK4007","LBRX","BK4233"],"gpt_icon":0},{"id":"2603576526","title":"LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603576526","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603576526?lang=en_us&edition=fundamental","pubTime":"2026-01-13 05:05","pubTimestamp":1768251900,"startTime":"0","endTime":"0","summary":"NEW YORK, Jan.  12, 2026  (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced that it has granted to Ellen Rose, the new Senior Vice Presi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/12/3217344/0/en/LB-Pharmaceuticals-Reports-Inducement-Grant-to-New-Employee-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4233","LB","LBRX","BK4213"],"gpt_icon":0},{"id":"2602377710","title":"Is LandBridge’s Ranch Deal, Debt Raise and Insider Buying Altering The Investment Case For LandBridge (LB)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2602377710","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602377710?lang=en_us&edition=fundamental","pubTime":"2026-01-09 22:28","pubTimestamp":1767968933,"startTime":"0","endTime":"0","summary":"Recently, LandBridge reported its third-quarter 2025 results, completed the acquisition of 1918 Ranch projected to add about US$20,000,000 in EBITDA for fiscal 2026, and saw senior executives including the CFO and General Counsel increase their holdings through Class A share purchases.\nAlongside these moves, LandBridge’s subsidiary DBR Land Holdings LLC priced a US$500,000,000 senior notes offering and the company launched a 2,500,000-share Class A public offering, signaling active efforts...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9612014-choice1-main-header/1585186829376","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9612014-choice1-main-header/1585186829376"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate-management-and-development/nyse-lb/landbridge/news/is-landbridges-ranch-deal-debt-raise-and-insider-buying-alte","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate-management-and-development/nyse-lb/landbridge/news/is-landbridges-ranch-deal-debt-raise-and-insider-buying-alte","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4233","BK4213","LB"],"gpt_icon":0},{"id":"2602872373","title":"Roth Capital Initiates Coverage on LB Pharmaceuticals With Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2602872373","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602872373?lang=en_us&edition=fundamental","pubTime":"2026-01-09 20:15","pubTimestamp":1767960941,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals Inc (LBRX) has an average rating of Buy and mean price target of $44.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ma","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LB","LBRX"],"gpt_icon":0},{"id":"2602321369","title":"LB Pharmaceuticals initiated with a Buy at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2602321369","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602321369?lang=en_us&edition=fundamental","pubTime":"2026-01-09 17:30","pubTimestamp":1767951020,"startTime":"0","endTime":"0","summary":"Roth Capital initiated coverage of LB Pharmaceuticals (LBRX) with a Buy rating and $31 price target The company’s LB-102, a Phase 3-ready schizophr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-initiated-with-a-buy-at-roth-capital-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-initiated-with-a-buy-at-roth-capital-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4233","LBRX","BK4007","LB","BK4213"],"gpt_icon":0},{"id":"2602534160","title":"LB Pharmaceuticals, Inc. (LBRX) Receives a New Rating from Roth MKM","url":"https://stock-news.laohu8.com/highlight/detail?id=2602534160","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602534160?lang=en_us&edition=fundamental","pubTime":"2026-01-09 13:35","pubTimestamp":1767936919,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals, Inc. received a Buy rating and a $31.00 price target from Roth MKM analyst Boobalan Pachaiyappan today. According to TipRanks, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lb-pharmaceuticals-inc-lbrx-receives-a-new-rating-from-roth-mkm-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lb-pharmaceuticals-inc-lbrx-receives-a-new-rating-from-roth-mkm-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LB","LBRX"],"gpt_icon":0},{"id":"2601872657","title":"Officer Bolling Harrison Fenner Acquires Common Shares of LandBridge Company LLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2601872657","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601872657?lang=en_us&edition=fundamental","pubTime":"2026-01-07 19:15","pubTimestamp":1767784548,"startTime":"0","endTime":"0","summary":"Bolling Harrison Fenner, an officer of Landbridge Company LLC, reported the acquisition of common shares of Landbridge Company LLC. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Landbridge Company LLC published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 07, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDL6dsJ3B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Officer Bolling Harrison Fenner Acquires Common Shares of LandBridge Company LLC","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LB","BK4233","BK4213"],"gpt_icon":0},{"id":"2601894562","title":"Press Release: LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture","url":"https://stock-news.laohu8.com/highlight/detail?id=2601894562","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601894562?lang=en_us&edition=fundamental","pubTime":"2026-01-06 20:00","pubTimestamp":1767700800,"startTime":"0","endTime":"0","summary":"NEW YORK, Jan. 06, 2026  -- LB Pharmaceuticals, Inc  , a clinical-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, and other neuropsychiatric diseases, today announced the appointments of Ellen Rose as Senior Vice President, Corporate Affairs and Lindsay Beaupre as Senior Vice President, People and Culture.Ms. Beaupre is a strategic and results-driven People and Culture executive with an extensive track record in the biotech and financial services sectors, driving organizational effectiveness, leadership capability, and cultural clarity. She partners closely with executive teams to build high-performing organizations during periods of growth and change. Most recently Ms. Beaupre was the Chief Administrative Officer at Lyndra Therapeutics, where she led enterprise-wide people and operational initiatives. Earlier in her career she held senior people leadership roles at prominent biotech companies such as Vertex Pharmaceuticals and Immunoge","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4120","TISI","LBRX","LB","BK4233","BK4213","BK4007"],"gpt_icon":0},{"id":"2595563792","title":"LB Group to Boost Capital, Introduce New Investors to Subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=2595563792","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595563792?lang=en_us&edition=fundamental","pubTime":"2025-12-30 20:30","pubTimestamp":1767097820,"startTime":"0","endTime":"0","summary":"LB Group  will increase the capital in subsidiary Henan Baililian New Materials by 2 billion yuan and introduce new investors, according to a Tuesday filing with the Shenzhen bourse.Following the capital increase, registered capital will rise to 2.48 billion yuan, with the company still holding 68.6% of Baililian New Materials.The investment will also involve the purchase of about 778 million yuan in capital by new shareholders Bank of Communications Financial Asset Investment, CITIC Financial Asset Management, Xingyin Financial Asset Investment, CITIC Financial Asset Investment, Henan Asset Management, BOC Financial Asset Investment, and Shenzhen Zhongxin Pengxiang Science and Technology Innovation Private Equity Investment Fund Partnership.Henan Baililian New Materials holds the largest single chloride process titanium dioxide production base in China with a production capacity of 400,000 tons per year, the filing said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0197","BK0229","BK4211","BK4213","LB","BK0187","002601","BK0131","BK0196","BK0028","ISBC","BK4233","BK0193"],"gpt_icon":0},{"id":"2595762637","title":"LB's Unit to Add Share in Partnership Fund for 63 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=2595762637","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595762637?lang=en_us&edition=fundamental","pubTime":"2025-12-30 15:39","pubTimestamp":1767080351,"startTime":"0","endTime":"0","summary":"LB Group's  unit, Longbai Sichuan Mining and Metallurgy, plans to acquire an additional partnership share in a private equity fund for 63 million yuan, according to a Shenzhen bourse filing on Tuesday.Longbai Sichuan aims to purchase a partnership interest worth 300 million yuan in the Henan Zhenxing Vanadium-Titanium Low-Carbon Development Private Equity Investment Fund Center .After the completion of the transaction, Longbai Sichuan's committed capital in the fund will rise to 99.9%, which is worth 997 million yuan.The titanium dioxide pigment producer's shares rose over 1% at the close.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0193","LB","BK4213","BK0028","002601","BK0187","BK0197","BK0229","BK4233","BK0131","BK0196"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.landbridgeco.com","stockEarnings":[{"period":"1week","weight":0.0501},{"period":"1month","weight":0.1713},{"period":"3month","weight":0.1935},{"period":"6month","weight":0.2668},{"period":"1year","weight":-0.0536},{"period":"ytd","weight":0.3987}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"L Brands, Inc. operates as a specialty retailers of body care, home fragrance products, soaps, and sanitizers. The company sells its products under the Bath & Body Works, White Barn, C.O. Bigelow, and other brand names. It operates approximately 1,750 Bath & Body Works stores in the United States and Canada, as well as online at BathandBodyWorks.com. In addition, the company has approximately 295 stores in 30 other countries operating under franchise, license, and wholesale arrangements. L Brands, Inc. was founded in 1963 and is headquartered in Columbus, Ohio.","yearOnYearQuotes":[{"month":1,"riseRate":0.615385,"avgChangeRate":0.023575},{"month":2,"riseRate":0.641026,"avgChangeRate":0.037322},{"month":3,"riseRate":0.589744,"avgChangeRate":0.019442},{"month":4,"riseRate":0.615385,"avgChangeRate":0.03057},{"month":5,"riseRate":0.5,"avgChangeRate":0.032148},{"month":6,"riseRate":0.45,"avgChangeRate":-0.016926},{"month":7,"riseRate":0.475,"avgChangeRate":0.023341},{"month":8,"riseRate":0.425,"avgChangeRate":-0.017396},{"month":9,"riseRate":0.6,"avgChangeRate":0.004595},{"month":10,"riseRate":0.641026,"avgChangeRate":0.026823},{"month":11,"riseRate":0.641026,"avgChangeRate":0.029598},{"month":12,"riseRate":0.461538,"avgChangeRate":-0.015843}],"exchange":"NYSE","name":"LandBridge Co. LLC","nameEN":"LandBridge Co. LLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LandBridge Co. LLC(LB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest LandBridge Co. LLC(LB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"LandBridge Co. LLC,LB,LandBridge Co. LLC股票,LandBridge Co. LLC股票老虎,LandBridge Co. LLC股票老虎国际,LandBridge Co. LLC行情,LandBridge Co. LLC股票行情,LandBridge Co. LLC股价,LandBridge Co. LLC股市,LandBridge Co. LLC股票价格,LandBridge Co. LLC股票交易,LandBridge Co. LLC股票购买,LandBridge Co. LLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LandBridge Co. LLC(LB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest LandBridge Co. LLC(LB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}